These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13765742)

  • 1. Effect of cortisone on distribution of fluorene-2, 7-di-(sulfonamido-2-naphthalene)-S35 in rats and mice.
    MALEJKA D; ARGUS MF; RAY FE
    Cancer Res; 1961 Jun; 21():673-7. PubMed ID: 13765742
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of rapid tissue growth on the uptake of fluorene-2, 7-di-(sulfonamido-2-naphthalene)-S35 by the liver and spleen of rats and hamsters.
    ARGUS MF; HUDSON MT; SEEPE TL; KANE JF; RAY FE
    Br J Cancer; 1962 Sep; 16(3):494-502. PubMed ID: 14013735
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of sulfur-35 labeled sulfonic acid derivatives of fluorene in tumor-bearing and tumor-free rats.
    MALEJKA D
    Br J Cancer; 1962 Mar; 16(1):170-6. PubMed ID: 14468861
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of cortisone treatment on the subcutaneous absorption and distribution of sulphacetamide in doubly nephrectomized rabbits.
    SCHOU J
    Acta Pharmacol Toxicol (Copenh); 1959; 15(3):217-20. PubMed ID: 13636869
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of new fluorene disulphonamido derivatives in rats with transplanted Walker carcinosarcoma.
    Malejka D
    Br J Cancer; 1966 Dec; 20(4):857-70. PubMed ID: 5964617
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoradiographic evaluation of the distribution of N,N'-bis(thiazole)-2,7-fluorene-disulphonamide-35S in organs of rats.
    Kasprzak K; Malejka D; Gabryel P
    Nature; 1965 Jun; 206(990):1266-7. PubMed ID: 5879796
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorene derivatives in rats bearing Walker carcinosarcoma.
    Malejka D
    Br J Cancer; 1965 Sep; 19(3):513-8. PubMed ID: 5833069
    [No Abstract]   [Full Text] [Related]  

  • 8. Concentration of sulphacetamide after constant intravenous infusion of untreated and cortisone-treated rabbits.
    SCHOU J
    Acta Pharmacol Toxicol (Copenh); 1960; 16():213-6. PubMed ID: 14443501
    [No Abstract]   [Full Text] [Related]  

  • 9. The metabolism of 4-ethylsulphonyl-naphthalene-1-sulphonamide.
    Bradshaw LR
    Biochem J; 1969 Sep; 114(2):33P-34P. PubMed ID: 5810097
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulfur-35 labeled high molecular weight sulfonamides as potential cancer diagnostic and therapeutic agents.
    ARGUS MF
    Bull Tulane Univ Med Fac; 1961 May; 20():151-64. PubMed ID: 13684184
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inclusion of methionine-S35 into liver proteins after the administration of cortisone and during starvation in rats].
    TRIUFANOV VF
    Vopr Med Khim; 1961; 7():354-8. PubMed ID: 13778104
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of radiation on distribution of S35-labeled sulfonamide.
    ARGUS MF; KANE JF; RAY FE
    Proc Soc Exp Biol Med; 1960 Jan; 103():87-91. PubMed ID: 13794190
    [No Abstract]   [Full Text] [Related]  

  • 13. [EFFECT OF CORTISONE ON THE DISTRIBUTION OF SULFANILAMIDE PREPARATIONS IN THE WHITE RAT ORGANISM DURING THE COURSE OF SERIAL THERAPY].
    KRYLOV IuF
    Farmakol Toksikol; 1964; 27():211-2. PubMed ID: 14193090
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of a new sulfonamide with prolonged action, 2-sulfonamido-5-methoxypyrimidine, in the animal organism].
    PLACKOVA Z; HAIS IM; WAGNER J
    Cesk Farm; 1962 Jul; 11():296-302. PubMed ID: 14487059
    [No Abstract]   [Full Text] [Related]  

  • 15. The enzymatic reduction of the N-hydroxy derivatives of 2-acetylaminofluorene and related carcinogens by tissue preparations.
    Lotlikar PD; Miller EC; Miller JA; Margreth A
    Cancer Res; 1965 Nov; 25(10):1743-52. PubMed ID: 5892967
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence of polycyclic aromatic hydrocarbon biodegradation in a contaminated aquifer by combined application of in situ and laboratory microcosms using (13)C-labelled target compounds.
    Bahr A; Fischer A; Vogt C; Bombach P
    Water Res; 2015 Feb; 69():100-109. PubMed ID: 25437342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the carcinogen, N-hydroxy-2-fluorenylbenzene-sulfonamide, by desulfonylation to N-2-fluorenylhydroxylamine in vivo.
    Malejka-Giganti D; Gutmann HR; Rydell RE; Yost Y
    Cancer Res; 1971 Jun; 31(6):778-88. PubMed ID: 4326035
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of adrenocorticotropic hormone and cortisone on the inclusion of methionine labeled by S35 into proteins of the liver, muscles and kidneys in alloxan diabetes].
    LEITES SM; PAVLOV GT
    Vopr Med Khim; 1959; 5():415-21. PubMed ID: 14415490
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modifications of hepatic metabolism in rats: action of cortisone on the utilization of glucose-U-C-14, acetate-I-C-14, glycine-I-C-14 and cystine-S35].
    Di Marco N; Antognetti RM; Perotti GF; Tacconi G
    Arch Sci Med (Torino); 1966 Jan; 121(1):1-12. PubMed ID: 5936379
    [No Abstract]   [Full Text] [Related]  

  • 20. A drug-induced change in the distribution and renal excretion of sulfonamides.
    ANTON AH
    J Pharmacol Exp Ther; 1961 Dec; 134():291-303. PubMed ID: 13861785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.